Stock Rich List
#128 on the corporate holders of 809 holders

California Capital Equity, LLC

10% owner at ImmunityBio.

$1.40B
in disclosed stock, −$27.6M (−1.94%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
128th of 809
Companies held
1
Largest holding
IBRX, 100.0% of total
Latest SEC filing
Mar 31, 2026
Listed but not counted
$3.32B

What the $1.40B is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
ImmunityBio IBRX
Common Stock
Through NantBio, Inc.
Reported jointly by 2 insiders; split evenly
130,852,907$6.57$860M61.6%Form 4, Mar 31, 2026
ImmunityBio IBRX
Common Stock
Directly29,757,911$6.57$196M14.0%Form 4, Mar 31, 2026
ImmunityBio IBRX
Common Stock
Through NantCancerStemCell, LLC
Reported jointly by 2 insiders; split evenly
23,778,967$6.57$156M11.2%Form 4, Mar 31, 2026
ImmunityBio IBRX
Common Stock
Indirectly (see filing footnote)
Reported jointly by 2 insiders; split evenly
16,303,493$6.57$107M7.7%Form 4, Mar 31, 2026
ImmunityBio IBRX
Common Stock
Indirectly (see filing footnote)5,618,326$6.57$36.9M2.6%Form 4, Mar 31, 2026
ImmunityBio IBRX
Common Stock
Through NantMobile, LLC
Reported jointly by 3 insiders; split evenly
3,328,973$6.57$21.9M1.6%Form 4, Mar 31, 2026
ImmunityBio IBRX
Common Stock
Through California Capital Equity, LLC
Reported jointly by 3 insiders; split evenly
2,794,471$6.57$18.4M1.3%Form 4, Mar 31, 2026

Share counts are the amounts California Capital Equity, LLC reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on California Capital Equity, LLC's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
ImmunityBio IBRX
Common Stock
Through Nant Capital, LLC
Held by an investment fund or partnership
251,018,873$6.57$1.65B—Form 4, Mar 31, 2026
ImmunityBio IBRX
Common Stock
Through Nant Capital, LLC
Held by an investment fund or partnership
246,412,277$6.57$1.62B—Form 4, Feb 22, 2026
ImmunityBio IBRX
Common Stock
Through Chan Soon-Shiong Family Foundation
Held for a foundation or charity
7,976,159$6.57$52.4M—Form 4, Mar 31, 2026

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
125Saba Capital Management, L.P.
10% owner, BlackRock ESG Capital Allocation Term Trust
$1.53B−$17.9M (−1.16%)
126Holding Frank B JR
Chairman and CEO, First Citizens BancShares
$1.44B−$50.5M (−3.39%)
127Bryant Hope Holding
Vice Chairwoman, First Citizens BancShares
$1.44B−$50.5M (−3.39%)
128California Capital Equity, LLC
10% owner, ImmunityBio
$1.40B−$27.6M (−1.94%)
129Ergen Two-Year June 2023 DISH GRAT
10% owner, EchoStar
$1.39B−$69.6M (−4.76%)
130Famatown Finance Ltd
10% owner, International Seaways
$1.39B−$4.4M (−0.32%)
131Electrum Strategic Opportunities Fund II L.P.
Director, Sinda
$1.38B−$55.3M (−3.86%)

Other ImmunityBio insiders

All IBRX insiders

Questions

How much stock does California Capital Equity, LLC own?

California Capital Equity, LLC holds $1,395,698,266 in listed stock based on SEC filings and current prices, mostly ImmunityBio (IBRX). That ranks 128th on the Stock Rich List.

Is this California Capital Equity, LLC's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

Files jointly with SEC filer 1189020.